However, OCA treatment did not result in the change in the luciferase intensity of the other truncated fragments compared with the control, suggesting that FXR activation could transcriptionally activate SOCS3 expression through binding to the −3182 bp to −2834 bp region of the SOCS3 promoter in colon cancer cells. This evidence concerns the gene NR1H4 and malignant colon neoplasm.